Author Correction: Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating β-Catenin (Acta Pharmacologica Sinica, (2013), 34, 1, (176-184), 10.1038/aps.2012.150);Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating β-catenin

Acta Pharmacologica Sinica

Volumn 34, Issue 1, 2013, Pages 176-184

  Zhang, Dong ^a,b   Chen, Zheng Gang ^c   Liu, Shao Hua ^a,b   Dong, Zuo Qing ^a   Dalin, Martin ^d   Bao, Shi San ^e   Hu, Ying Wei ^b   Wei, Feng Cai ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c QINGDAO UNIVERSITY   (China)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

galectin 3; metastasis; MMP 9; RNA interference; tongue cancer; tumor invasion; Wnt signaling pathway; catenin

Indexed keywords

BETA CATENIN; GALECTIN 3; GELATINASE B; GLYCOGEN SYNTHASE KINASE 3BETA; MATRIGEL; MESSENGER RNA; PROTEIN KINASE B; SMALL INTERFERING RNA; WNT PROTEIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GALECTIN 3 GENE; GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TONGUE CANCER; TRANSIENT TRANSFECTION; WESTERN BLOTTING;

EID: 84872085726     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/s41401-022-00979-3     Document Type: Erratum

References (41)

1. Ferrari D, Codeca C, Fiore J, Moneqhini L, Bosari S, Foa P. Biomolecular markers in cancer of the tongue. J Oncol 2009;2009:412908.
2. Sano D, Myers JN. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 2007;26:645-62. (Pubitemid 350115112)
3. Califce S, Castronovo V, Van Den Brule F. Galectin-3 and cancer. Int J Oncol 2004;25:983-92.
4. Nangia-Makker P, Nakahara S, Hogan V, Raz A. Galectin-3 in apoptosis, a novel therapeutic target. J Bioenerg Biomembr 2007;39:79-84. (Pubitemid 46877176)
5. Kobayashi T, Shimura T, Yajima T, Kubo N, Araki K, Wada W, et al. Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cell. Clin Exp Metastasis 2011;28:367-76.
6. Kim SJ, Choi IJ, Cheong TC, Lee SJ, Lotan R, Park SH, et al. Galectin-3 increase gastric cancer cell motility by up-regulating fascin-1 expression. Gastroenterology 2010;138:1035-45.
7. Wang Y, Nangia-Makker P, Tait L, Balan V, Hogan V, Pienta KJ, et al. Regulation of prostate cancer progression by galectin-3. Am J Pathol 2009;174:1515-23.
8. Tsuboi K, Shimura T, Masuda N, Ide M, Tsutsumi S, Yamaguchi S, et al. Galectin-3 expression in colorectal cancer: relation to invasion and metastasis. Anticancer Res 2007;27(4B):2289-96. (Pubitemid 47228066)
9. Kobayashi T, Shimura T, Yajima T, Kubo N, Araki K, Tsutsumi S, et al. Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of beta-catenin. Int J Cancer 2011;129:2775-86.
10. Mayoral MA, Mayoral C, Meneses A, Villalvazo L, Guzman A, Espinosa B, et al. Identifcation of galectin-3 and mucin-type O-glycans in breast cancer and its metastasis to brain. Cancer Invest 2008;26:615-23. (Pubitemid 351918585)
11. Honjo Y, Inohara H, Akahani S, Yoshii T, Takenaka Y, Yoshida J, et al. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 2000;6:4635-40. (Pubitemid 32110398)
12. Alves PM, Godoy GP, Gomes DQ, Medeiros AM, de Souza LB, da Silveira EJ, et al. Significance of galectins-1, -3, -4, and -7 in the progression of squamous cell carcinoma of the tongue. Pathol Res Pract 2011;207:236-40.
13. Amin N, Vincan E. The Wnt signaling pathways and cell adhesion. Front Biosci 2012;17:784-804.
14. Wang Z, Ma Q. Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer. Med Hypotheses 2007;69:816-20. (Pubitemid 47248125)
15. Bian S, Bai JP, Chapin H, Le Moellic C, Dong H, Caplan M, et al. Interactions between β-catenin and the HSIo potassium channel regulates HSIo surface expression. PLoS One 2011;6:e28264.
16. Stein U, Arlt F, Smith J, Sack U, Herrmann P, Walther W, et al. Intervening in beta-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis. Neoplasia 2011;13:131-44.
17. Iwai S, Yonekawa A, Harada C, Hamada M, Katagiri W, Nakazawa M, et al. Involvement of the Wnt-beta-catenin pathway in invasion and migration of oral squamous carcinoma cells. Int J Oncol 2010;37:1095-103.
18. Wu B, Hu K, Li S, Zhu J, Gu L, Shen H, et al. Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer. Oncol Rep 2012;27:101-8.
19. Wu B, Li S, Sheng L, Zhu J, Gu L, Shen H, et al. Metformin inhibits the develop ment and metastasis of ovarian cancer. Oncol Rep 2012;28:903-8.
20. Shin HS, Oh HY. The effect of platelet-rich plasma on wounds of OLETF rats using expression of matrix metalloproteinase-2 and -9 mRNA. Arch Plast Surg 2012;39:106-12.
21. Kim SJ, Shin JY, Cheong TC, Choi IJ, Lee YS, Park SH, et al. Galectin-3 gemline variant at position 191 enhances nuclear accumulation and activation of β-catenin in gastric cancer. Clin Exp Metastasis 2011;28:743-50.
22. Shi Y, He B, Kuchenbecker KM, You L, Xu Z, Mikami I, et al. Inhibition of Wnt-1 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells. Int J Cancer 2007;121:1175-81. (Pubitemid 47293782)
23. Song Y, Yang QX, Zhang F, Meng F, Li H, Dong Y, et al. Suppression of nasopharyngeal carcinoma cell by targeting β-catenin signaling pathway. Cancer Epidemiol 2012;36:e116-21.
24. Saussez S, Decaestecker C, Mahillon V, Cludts S, Capouillez A, Chevalier D, et al. Galectin-3 upregulation during tumor progression in head and neck cancer. Laryngoscope 2008;118:1583-90.
25. Shimura T, Takenaka Y, Fukumori T, Tsutsumi S, Okada K, Hogan V, et al. Implication of galectin-3 in Wnt signaling. Cancer Res 2005;65:3535-7. (Pubitemid 40616326)
26. Reya, T, Clevers, H. Wnt signaling in stem cells and cancer. Nature 2005;434:843-50. (Pubitemid 40558990)
27. Tenbaum SP, Ordonez-Moran P, Puig I, Chicote I, Arques O, Landolf S, et al. β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med 2012; doi: 10.1038/nm.2772.
28. Song S, Mazurek N, Liu C, Sun Y, Ding QQ, Liu K, et al. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity. Cancer Res 2009;69:1343-9.
29. Mazurek N, Sun YJ, Liu KF, Gilcrease MZ, Schober W, Nangia-Makker P, et al. Phosphorylated galectin-3 mediates tumor necrosis factorrelated apoptosis-inducing ligand signaling by regulating phosphatase and tensin homologue deleted on chromosome 10 in human breast carcinoma cells. J Biol Chem 2007;282:21337-48. (Pubitemid 47099965)
30. Xia YX, Lu L, Wu ZS, Pu LY, Sun BC, Wang XH. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice. Hepatobiliary Pancreat Dis Int 2012;11:278-84.
31. Maseki S, Ijichi K, Tanaka H, Fujii M, Hasegawa Y, Ogawa T, et al. Acquisition of EMT phenotype in the geftinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signaling pathway. Br J Cancer 2012;106:1196-204.
32. Lu KW, Tsai ML, Chen JC, Hsu SC, Hsia TC, Lin MW, et al. Gypenosides inhibited invasion and migration of human tongue cancer SCC4 cells through down-regulation of NF-κB and matrix metalloproteinase-9. Anticancer Res 2008;28:1093-9.
33. Giudice FS, Dal Vechio AM, Abrahao AC, Sperandio FF, Pinto-Junior Ddos S. Different expression patterns of pAkt, NF-κB and cyclin D1 proterins during the invasion process of head and neck squamous cell carcinoma: an in vitro approach. J Oral Pathol Med 2011;40:405-11.
34. Hu K, Li SL, Gan YH, Wang CY, Yu GY. Epiregulin promotes migration and invasion of salivary adenoid cystic carcinoma cell line SACC-83 through activation of ERK and Akt. Oral Oncol 2009;45:156-63.
35. Hittelet A, Camby I, Nagy N, Leqendre H, Bronckart Y, Decaestecker C, et al. Binding sites for Lewis antigens are expressed by human colon cancer cells and negatively affect their migration. Lab Invest 2003;83:777-87. (Pubitemid 36723687)
36. Debray C, Vereecken P, Belot N, Teillard P, Brion JP, Pandolfo M, et al. Multifaceted role of galectin-3 on human glioblastoma cell motility. Biochem Biophys Res Commun 2004;325:1393-8. (Pubitemid 39539230)
37. Sant'ana JM, Chammas R, Liu FT, Nonogaki S, Cardoso SV, Loyola AM, et al. Activation of the Wnt/Beta-catenin signaling pathway during oral carcinogenesis process is not influenced by the absence of galectin-3 in mice. Anticancer Res 2011;31:2805-11.
38. Dumic J, Dabelic S, Flogel M. Galectin-3: an open-ended story. Biochim Biophys Acta 2006;1760:616-35. (Pubitemid 44382499)
39. Eude-Le Parco I, Gendronneau G, Dang T, Delacour D, Thijssen VL, Edelmann W, et al. Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dessemination in mice. Glycobiology 2009;19:68-75.
40. Jiang HB, Xu M, Wang XP. Panceratic stellate cells promote proliferation and invasiveness of human pancreatic cancer cells via galectin-3. Word J Gastroenterol 2008;14:2023-8. (Pubitemid 351795821)
41. Kim SJ, Oh JS, Shin JY, Lee KD, Sung KW, Nam SJ, et al. Development of micro RNA-145 for therapeutic application in breast cancer. J Control Release 2011;155:427-34.